Posted in Web What to Know: FDA Approves Non-Opioid Pain Medication, Journavx January 31, 2025 The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years. https://www.usnews.com/news/health-news/articles/2025-01-31/what-to-know-fda-approves-non-opioid-pain-medication-journavx